405 abstracts found.



Results filter

Understanding the role of multimorbidity on symptomatic presentation and early diagnosis of cancer

Year:

Session type:

Katriina Whitaker1
1University of Surrey

Myeloid cells in the ovarian cancer microenvironment

Year:

Session type:

Fran Balkwill1
1Barts Cancer Institute

Inflammation driven cancer: Genes, cells and microbes

Year:

Session type:

Fiona Powrie1
1Kennedy Institute of Rheumatology, University of Oxford

The role of individual and system factors on inequalities in cancer care and outcomes

Year:

Session type:

Bernard Rachet1
1London School of Hygiene and Tropical Medicine

NHS Cancer Strategy

Year:

Session type:

David Fitzgerald1
1NHS England

Macrophages: Bad Actors in Cancer

Year:

Session type:

Jeffrey Pollard1
1The University of Edinburgh

Evolutionary dynamics of cancer subclones

Year:

Session type:

Trevor Graham1
1Barts Cancer Institute

Tumour microenvironment and radiation – friend or foe?

Year:

Session type:

Kaye Williams1
1University of Manchester

Pre-clinical models of glioblastoma that enable more accurate evaluation of new treatment combinations

Year:

Session type:

Anthony Chalmers1
1Glasgow Centre for Cancer Research

Early pancreatic cancer diagnostics

Year:

Session type:

Stephen Pereira1
1University College London

Targeting the DNA Damage Response with a Selective CHK1 Inhibitor

Year:

Session type:

Ian Collins1
1The Institute of Cancer Research

DNA damage repair inhibitors and radiation- are normal tissues spared?

Year:

Session type:

Susan Short1
1University of Leeds

Why is cancer so difficult?

Year:

Session type:

Martin Christlieb1
1University of Oxford

Identifying and interpreting robust genetic dependencies in cancer cell lines

Year:

Session type:

Colm Ryan1
1University College Dublin

Discovery of first-in class, selective and noncovalent small molecule inhibitors of DNMT1

Year:

Session type:

Allan Jordan1
1CRUK Manchester Institute

The challenges of rare cancer: Time for change

Year:

Session type:

Richard Adams1
1Cardiff University

De-mystifying today’s science

Year:

Session type:

Elaine Vickers1
1Science Communicated

Applying genomics to tailor colorectal cancer screening in primary care

Year:

Session type:

Jon Emery1
1Centre for Cancer Research and Department of General Practice, University of Melbourne

Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial

Year:

Session type:

Richard Martin1
1University of Bristol

Designing trials in smaller populations

Year:

Session type:

Matthew Sydes1
1MRC Clinical Trials Unit at UCL

Why is behaviour change so difficult?

Year:

Session type:

Theresa Marteau1
1University of Cambridge

New approaches in the diagnosis of lung cancer – from bench to primary care

Year:

Session type:

Richard Neal1
1University of Leeds

Methodological issues in precision oncology trials

Year:

Session type:

Lucinda Billingham1
1Cancer Research UK Clinical Trials Unit, University of Birmingham

Core Outcomes Sets for trials and Core Information Sets for consultations: keeping them patient centred

Year:

Session type:

Jane Blazeby1,Angus McNair1
1University of Bristol

GvHD: uncoupling immunopathology from the graft-vs-leukemia effect.

Year:

Session type:

Burkhard Becher1
1University of Zurich

Intra-operative Electron beam radiotherapy for advanced and recurrent abdominopelvic malignancies in the UK: Development, implementation, and medium term results

Year:

Session type:

Alex Mirnezami1
1University of Southampton

Computational Pathology: Challenges and Opportunities

Year:

Session type:

Nasir Rajpoot1
1University of Warwick

Best practices for integration of Patient-Reported Outcomes (PROs) into trials

Year:

Session type:

Derek Kyte1
1University of Birmingham

Precision oncology

Year:

Session type:

Sandesh Kc1,Thomas King2,David Mak2,Rupesh Bhatt2,Alan Doherty2,Richard Viney2,Prashant Patel2,Brian Kelly2

1University Hospital Birmingham,2UHB

A personalised approach to treating patients with haematological malignancies

Year:

Session type:

Susanne Saussele1
1Universitätsmedizin Mannheim

Surgery-dependent Translational Research

Year:

Session type:

Richard Shaw1
1NIHR Cancer Research Network (NCRN)

Digital Pathology & Artificial Intelligence, the Third Revolution in Pathology

Year:

Session type:

Manuel Salto-Tellez1
1Queen's University Belfast

Molecular archaeology of cancer

Year:

Session type:

Peter Van Loo1,2

1The Francis Crick Institute, London, UK,2University of Leuven, Leuven, Belgium

Molecular Imaging of Immunotherapies

Year:

Session type:

Sanjiv Gambhir1
1Stanford university

Clone Wars in Leukaemia: Are there lessons for all cancers?

Year:

Session type:

Paresh Vyas1
1University of Oxford

Lung Cancer IO – hi ho

Year:

Session type:

Mary O'Brien1
1Royal Marsden NHS Hospital

Inhibition of the pro-tumorigenic effects of TGFbeta in tumor therapy

Year:

Session type:

Carl-Henrik Heldin1
1Uppsala University

Applying genetic information to prevent colorectal cancer

Year:

Session type:

Malcolm Dunlop1
1University of Esinburgh

Tumor-educated platelets for the detection and monitoring of cancer

Year:

Session type:

Thomas Wurdinger1
1VU University Medical Center

Challenges in Managing the Immune Related Toxicities of Cancer Immunotherapy

Year:

Session type:

Paul Nathan1
1Mount Vernon Hospital

Deregulated TGF-β signalling in cancer

Year:

Session type:

Caroline Hill1
1The Francis Crick Institute

Co-existing Tumour-Immune Microenvironments in Advanced Ovarian Cancer

Year:

Session type:

Martin Miller1
1University of Cambridge

Use and safety of novel alternative nicotine delivery devices: a role for cancer harm reduction?

Year:

Session type:

Lion Shahab1
1University College London

Surviving the Cure: Blood and Marrow Transplantation as Model For Cancer Survivorship

Year:

Session type:

Navneet Majhail1
1Cleveland Clinic

Role of TGF-beta in glioblastoma

Year:

Session type:

Joan Seoane1
1Vall d'Hebron University Hospital

Adipocytes in the melanoma microenvironment

Year:

Session type:

Richard White1
1Memorial Sloan-Kettering Cancer Center

Air pollution and cancer

Year:

Session type:

John Cherrie1
1Heriot Watt University and the Institute of Occupational Medicine

Identification of novel therapeutic targets for triple negative breast cancer through integrative kinomics

Year:

Session type:

Roger Daly1
1Department of Biochemistry and Molecular Biology, Monash University

Role of the gut microbiome in causing, detecting and treating coloretal cancer.

Year:

Session type:

Paul O'Toole1
1School of Microbiology and APC Microbiome Inst

Precision medicine for melanoma: are we there yet?

Year:

Session type:

Richard Marais1
1CR-UK Manchester Institute